A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis
Not yet recruiting
Almirall, S.A.
Phase 3
2022-05-01
The purpose of the study is to evaluate the safety, tolerability and treatment effect of
tirbanibulin ointment 1% when applied to a field of approximately 100 cm^2 on the face or
balding scalp.
A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
Not yet recruiting
Almirall, S.A.
Phase 4
2022-08-01
The purpose of the study is to evaluate the incidence of biopsy confirmed invasive squamous
cell carcinoma (SCC) in the selected treatment field (TF) after administration of topical
tirbanibulin 10 milligram (mg)/gram (g) ointment or diclofenac sodium 3 percent (%) gel over
the 3-year study period.
Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
Not yet recruiting
Austin Institute for Clinical Research
Phase 2
2023-02-15
This is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess
Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell
carcinoma (sBCC) on the neck, trunk, or extremities (excluding, axilla, anogenital, and
face/scalp).
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Recruiting
Almirall, S.A.
Phase 4
2023-01-17
The purpose of the study is to assess treatment satisfaction on Day 57 in participants with
Actinic Keratoses (AK) of the face or scalp following treatment with tirbanibulin ointment 1
percent (%) administered once daily for 5 consecutive days.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
